Adaptive Biotechnologies Corp

By person

29 insiders · 931 transactions

81.1×

Chad Robins holds 81.1 times base salary in stock. $56.69M of shares against $698.26K in salary for 2025.

Salary from the company's own proxy. The shares are what Chad Robins last reported holding, valued at $26.00, the price Common Stock was last bought or sold at on the open market here, on 26 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

VIKING GLOBAL INVESTORS LP entity

10% owner

$5.00M (1)

$302.14M (3)

−$297.14M

29,993,708

18.79%

$779.84M

+2,005%

VIKING GLOBAL PERFORMANCE LLC entity

10% owner

$5.00M (1)

$246.49M (2)

−$241.49M

30,993,708

19.42%

$805.84M

+2,075%

GOEL DAVID E.

Director

—

$112.23M (10)

−$112.23M

12,310,594

7.71%

$320.08M

—

ROBINS CHAD M

CEO and Chairman

—

$89.34M (160) scheduled

−$89.34M

2,180,518

1.37%

$56.69M

+19.3%

RUBINSTEIN JULIE

President and COO

—

$82.18M (198) scheduled

−$82.18M

377,802

0.2367%

$9.82M

—

ROBINS HARLAN S

Chief Scientific Officer

—

$63.17M (153) scheduled

−$63.17M

812,058

0.5088%

$21.11M

—

Cohen Chad M

Chief Financial Officer

$20.00K (1)

$47.01M (81) scheduled

−$46.99M

21,604

0.0135%

$561.70K

—

BENZENO SHARON

Chief Commercial Ofc Imm Med

—

$29.75M (50) scheduled

−$29.75M

221,278

0.1386%

$5.75M

—

LO FRANCIS

Chief People Officer

—

$12.69M (38) scheduled

−$12.69M

230,713

0.1446%

$6.00M

—

HILL NANCY LOUISE

EVP, Operations & Program Mana

$224.00K (4)

$11.38M (11) scheduled

−$11.15M

10,300

0.0065%

$267.80K

−77.2%

ZOLTNERS ANDRIS A

Director

—

$9.14M (1) scheduled

−$9.14M

3,621,016

2.27%

$94.15M

—

BALDO LANCE

Chief Medical Officer

—

$7.43M (25) scheduled

−$7.43M

17,171

0.0108%

$446.45K

—

SANG CHARLES

SVP, External Affairs

—

$6.49M (4) scheduled

−$6.49M

0.0000%

$0.00

—

GRIFFIN MICHELLE RENEE

Director

—

$5.88M (25) scheduled

−$5.88M

15,625

0.0098%

$406.25K

—

Pellini Michael J

Director

—

$5.27M (4) scheduled

−$5.27M

69,690

0.0437%

$1.81M

—

Taylor Stacy L

SVP and General Counsel

—

$4.79M (40) scheduled

−$4.79M

139,365

0.0873%

$3.62M

+10,620%

PISKEL KYLE

Chief Financial Officer

—

$3.74M (17) scheduled

−$3.74M

256,725

0.1609%

$6.67M

—

HERSHBERG ROBERT

Director

—

$3.42M (25) scheduled

−$3.42M

46,683

0.0293%

$1.21M

—

BOBULSKY SUSAN

Chief Commercial Officer, MRD

—

$3.27M (13) scheduled

−$3.27M

396,989

0.2487%

$10.32M

+233.2%

NEUPERT PETER M

Director

—

$3.21M (4) scheduled

−$3.21M

130,625

0.0818%

$3.40M

—

DOBMEIER ERIC

Director

—

$2.11M (11) scheduled

−$2.11M

1,504

0.0009%

$39.10K

—

PETERSON TYCHO

Chief Financial Officer

—

$2.02M (6) scheduled

−$2.02M

531,553

0.3331%

$13.82M

—

ADAMS R MARK

Chief Operating Officer

—

$1.66M (20)

−$1.66M

175,361

0.1099%

$4.56M

—

Palaniappan Jyoti

SVP, Diagnostics, T-Detect

—

$877.35K (8) scheduled

−$877.35K

9,158

0.0057%

$238.11K

—

SOOD NITIN

Chief Commercial Officer, MRD

—

$689.91K (6)

−$689.91K

214,808

0.1346%

$5.59M

—

OWEN KATEY EINTERZ

Director

—

$249.99K (1)

−$249.99K

66,100

0.0414%

$1.72M

—

THORSEN HENNING

SVP, Commercial Operations

—

29,061

0.0182%

$755.59K

—

Trigg Leslie

Director

—

25,907

0.0162%

$673.58K

—

Conroy Kevin T

Director

—

22,968

0.0144%

$597.17K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

BOBULSKY SUSAN

10 Aug 2026

Chief Commercial Officer, MRD

Sold on a plan

3,000

$25.00

$75.00K

BOBULSKY SUSAN

30 Jul 2026

Chief Commercial Officer, MRD

Sold on a plan

1,299

$24.00

$31.18K

BOBULSKY SUSAN

16 Jul 2026

Chief Commercial Officer, MRD

Sold on a plan

5,000

$23.00

$115.00K

ROBINS HARLAN S

2 Jul 2026

Chief Scientific Officer

Sold on a plan

146,889

$22.45

$3.30M

ROBINS HARLAN S

2 Jul 2026

Chief Scientific Officer

Sold on a plan

239,351

$21.74

$5.20M

BOBULSKY SUSAN

1 Jul 2026

Chief Commercial Officer, MRD

Sold on a plan

487

$22.00

$10.71K

BOBULSKY SUSAN

25 Jun 2026

Chief Commercial Officer, MRD

Sold on a plan

5,000

$20.50

$102.50K

ROBINS HARLAN S

16 Jun 2026

Chief Scientific Officer

Sold on a plan

6,160

$18.01

$110.94K

ROBINS HARLAN S

15 Jun 2026

Chief Scientific Officer

Sold on a plan

100,000

$17.37

$1.74M

BOBULSKY SUSAN

11 Jun 2026

Chief Commercial Officer, MRD

Sold on a plan

5,000

$19.00

$95.00K

BOBULSKY SUSAN

4 Jun 2026

Chief Commercial Officer, MRD

Sold on a plan

11,000

$18.00

$198.00K

ROBINS CHAD M

8 Apr 2026

CEO and Chairman

Sold on a plan

37,263

$15.19

$566.02K

ROBINS HARLAN S

8 Apr 2026

Chief Scientific Officer

Sold on a plan

10,000

$14.85

$148.50K

ROBINS CHAD M

6 Apr 2026

CEO and Chairman

Sold on a plan

83,332

$14.41

$1.20M

LO FRANCIS

11 Mar 2026

Chief People Officer

Sold on a plan

30,593

$14.08

$430.75K

ROBINS CHAD M

3 Mar 2026

CEO and Chairman

Sold on a plan

2,380

$16.15

$38.44K

ROBINS CHAD M

3 Mar 2026

CEO and Chairman

Sold on a plan

50,703

$15.49

$785.39K

ROBINS HARLAN S

3 Mar 2026

Chief Scientific Officer

Sold on a plan

14,233

$16.52

$235.13K

ROBINS CHAD M

2 Mar 2026

CEO and Chairman

Sold on a plan

289,024

$15.82

$4.57M

ROBINS HARLAN S

2 Mar 2026

Chief Scientific Officer

Sold on a plan

10,000

$15.72

$157.20K

ROBINS CHAD M

27 Feb 2026

CEO and Chairman

Sold on a plan

182,891

$15.99

$2.92M

ROBINS HARLAN S

3 Feb 2026

Chief Scientific Officer

Sold on a plan

8,120

$19.00

$154.28K

ROBINS CHAD M

2 Feb 2026

CEO and Chairman

Sold on a plan

124,998

$18.44

$2.30M

ROBINS HARLAN S

2 Feb 2026

Chief Scientific Officer

Sold on a plan

34,668

$18.60

$644.82K

ROBINS HARLAN S

6 Jan 2026

Chief Scientific Officer

Sold on a plan

10,000

$16.44

$164.40K

ROBINS CHAD M

5 Jan 2026

CEO and Chairman

Sold on a plan

124,998

$15.59

$1.95M

ROBINS HARLAN S

4 Dec 2025

Chief Scientific Officer

Sold on a plan

10,000

$16.61

$166.10K

ROBINS HARLAN S

3 Dec 2025

Chief Scientific Officer

Sold on a plan

27,212

$18.61

$506.42K

ROBINS CHAD M

1 Dec 2025

CEO and Chairman

Sold on a plan

124,998

$18.94

$2.37M

ROBINS CHAD M

26 Nov 2025

CEO and Chairman

Sold on a plan

35,736

$19.68

$703.28K

ROBINS CHAD M

12 Nov 2025

CEO and Chairman

Sold on a plan

1,867

$15.00

$28.01K

ROBINS CHAD M

11 Nov 2025

CEO and Chairman

Sold on a plan

1,237

$14.57

$18.02K

ROBINS CHAD M

10 Nov 2025

CEO and Chairman

Sold on a plan

86,161

$14.73

$1.27M

ROBINS HARLAN S

10 Nov 2025

Chief Scientific Officer

Sold on a plan

10,000

$14.82

$148.20K

GRIFFIN MICHELLE RENEE

6 Mar 2025

Director

Sold on a plan

15,664

$7.94

$124.37K

Taylor Stacy L

22 Aug 2024

SVP and General Counsel

Sold on a plan

26,922

$4.50

$121.08K

SOOD NITIN

8 Aug 2023

Chief Commercial Officer, MRD

Sold on a plan

10,550

$6.54

$69.00K

SOOD NITIN

7 Aug 2023

Chief Commercial Officer, MRD

Sold on a plan

5,652

$6.78

$38.32K

ADAMS R MARK

11 Apr 2023

Chief Operating Officer

Sold on a plan

2,308

$8.63

$19.92K

ADAMS R MARK

10 Apr 2023

Chief Operating Officer

Sold on a plan

817

$8.50

$6.94K

Showing 250 of 931 transactions. The figures above use every one of them.

Adaptive Biotechnologies Corp

By person

Individual transactions

What was left out